---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-089074"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:27:02.091489+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Larimar posts updated corporate presentation for investor meetings

## Summary
- Company posted updated slide presentation on June 23, 2025 for use in meetings with investors and analysts.
- No financial results, guidance changes, or material business events were disclosed in the filing.
- Presentation covers general corporate overview; specific new content could not be extracted from the exhibit.
- LRMR trades on Nasdaq; no material updates to pipeline or financial position reported.

## SEC filing metadata
- accession: 0000950170-25-089074
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000095017025089074/0000950170-25-089074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000095017025089074/lrmr-20250623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-089074
- JSON: https://secwatch.observer/filing/0000950170-25-089074.json
- Plain text: https://secwatch.observer/filing/0000950170-25-089074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.